Here, we demonstrate that the gypenosides Gyp L and Gyp LI could reduce the content of arachidonic acid in ccRCC cells by downregulating cPLA2, thereby inhibiting the growth of renal cancer. This evidence concerns the gene PLA2G4A and nonpapillary renal cell carcinoma.